On May 8, the U.S. Food and Drug Administration (FDA) approved the Senza spinal cord stimulation (SCS) system to help manage chronic intractable pain of the trunk and/or limbs. The system can reduce pain without paresthesia by providing high frequency stimulation (at 10 KHz) and low stimulation amplitudes. Read more.
FDA approves new spinal cord stimulation system for pain
The views and opinions expressed here are those of the author and do not necessarily reflect the opinions or recommendations of the American Nurses Association, the Editorial Advisory Board members, or the Publisher, Editors and staff of American Nurse Journal. This has not been peer reviewed.